Bremelanotide ($ Vyleesi)
Melanocortin receptor agonist
- Sexual dysfunction Female
- Can cause permanent skin discoloration
Features
Dosing
Bremelanotide 1.75mg/0.3mL, 0.3mL SC inj 45 minutes before sexual activity (max 8 per month)
Management
A hormonal injection that is FDA approved but not very desirable because it can cause discoloration of skin at injection site.
EMR Text
Sexual dysfunction in women
Bremelanotide use based on FDA approval for hypoactive female sexual desire.
Bremelanotide risks, including skin discoloration, reviewed with patient.